Literature DB >> 28130640

Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.

Edward B Lee1,2,3, Sílvia Porta4,5, G Michael Baer6, Yan Xu4,5, EunRan Suh4,5, Linda K Kwong4,5, Lauren Elman6, Murray Grossman6, Virginia M-Y Lee4,5, David J Irwin6, Vivianna M Van Deerlin4,5, John Q Trojanowski4,5.   

Abstract

Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) can typically be categorized into one of four distinct histopathologic patterns of TDP-43 pathology, types A to D. The strength of this histopathologic classification lies in the association between FTLD-TDP subtypes and various clinical and genetic features of disease. Seven cases of FTLD-TDP were identified here which were difficult to classify based on existing pathologic criteria. Distinct features common to these cases included TDP-43 aggregates over a wide neuroanatomic distribution comprised of granulofilamentous neuronal inclusions, abundant grains, and oligodendroglial inclusions. TDP-43 aggregates were phosphorylated and associated with loss of normal nuclear TDP-43 protein (nuclear clearance) but were negative for ubiquitin. Biochemical analysis confirmed the presence of insoluble and phosphorylated TDP-43 and also revealed a distinct pattern of TDP-43 C-terminal fragments relative to other FTLD-TDP subtypes. Finally, these cases were uniformly associated with a very rapid clinical course culminating in death within ~3 years of disease onset. We suggest that these cases may represent a unique clinicopathologic subtype of FTLD-TDP which we provisionally call "type E." The immature appearance of TDP-43 aggregates, widespread distribution, uniform biochemical profile and rapid clinical course highlights the clinical and pathologic variability within FTLD-TDP, and raises the possibility that type E neuropathology is the sequelae of a particularly virulent strain of TDP-43 proteinopathy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28130640      PMCID: PMC5521959          DOI: 10.1007/s00401-017-1679-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

Authors:  J Q Trojanowski; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2007-12       Impact factor: 8.090

Review 2.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

3.  Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Authors:  Mark S Forman; Ian R Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David A Drachman; Bharati S Jhaveri; Jason H Karlawish; Alan Pestronk; Thomas W Smith; Pang-Hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Journal:  J Neuropathol Exp Neurol       Date:  2006-06       Impact factor: 3.685

4.  Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Hiroshi Tsuji; Takashi Nonaka; Makiko Yamashita; Masami Masuda-Suzukake; Fuyuki Kametani; Haruhiko Akiyama; David M A Mann; Akira Tamaoka; Masato Hasegawa
Journal:  Biochem Biophys Res Commun       Date:  2011-11-22       Impact factor: 3.575

5.  White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.

Authors:  Masanori Hiji; Tetsuya Takahashi; Hiromasa Fukuba; Hiroshi Yamashita; Tatsuo Kohriyama; Masayasu Matsumoto
Journal:  Acta Neuropathol       Date:  2008-06-27       Impact factor: 17.088

6.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies.

Authors:  Felix Geser; Maria Martinez-Lage; John Robinson; Kunihiro Uryu; Manuela Neumann; Nicholas J Brandmeir; Sharon X Xie; Linda K Kwong; Lauren Elman; Leo McCluskey; Chris M Clark; Joe Malunda; Bruce L Miller; Earl A Zimmerman; Jiang Qian; Vivianna Van Deerlin; Murray Grossman; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-02

7.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

8.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

9.  A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.

Authors:  Jon B Toledo; Vivianna M Van Deerlin; Edward B Lee; EunRan Suh; Young Baek; John L Robinson; Sharon X Xie; Jennifer McBride; Elisabeth M Wood; Theresa Schuck; David J Irwin; Rachel G Gross; Howard Hurtig; Leo McCluskey; Lauren Elman; Jason Karlawish; Gerard Schellenberg; Alice Chen-Plotkin; David Wolk; Murray Grossman; Steven E Arnold; Leslie M Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-24       Impact factor: 21.566

10.  Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.

Authors:  EunRan Suh; Edward B Lee; Donald Neal; Elisabeth M Wood; Jon B Toledo; Lior Rennert; David J Irwin; Corey T McMillan; Bryan Krock; Lauren B Elman; Leo F McCluskey; Murray Grossman; Sharon X Xie; John Q Trojanowski; Vivianna M Van Deerlin
Journal:  Acta Neuropathol       Date:  2015-05-29       Impact factor: 17.088

View more
  74 in total

1.  Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination.

Authors:  Jia Wang; Wan Yun Ho; Kenneth Lim; Jia Feng; Greg Tucker-Kellogg; Klaus-Armin Nave; Shuo-Chien Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

2.  Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.

Authors:  Takayasu Mishima; Shunsuke Koga; Wen-Lang Lin; Koji Kasanuki; Monica Castanedes-Casey; Zbigniew K Wszolek; Shin J Oh; Yoshio Tsuboi; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

3.  Integrated neurodegenerative disease autopsy diagnosis.

Authors:  Edward B Lee
Journal:  Acta Neuropathol       Date:  2018-03-03       Impact factor: 17.088

4.  Speech and Language Presentations of FTLD-TDP Type B Neuropathology.

Authors:  Daniel J Lee; Eileen H Bigio; Emily J Rogalski; M-Marsel Mesulam
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

5.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

Review 6.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

7.  Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.

Authors:  Daniel T Ohm; Claire Peterson; Rebecca Lobrovich; Katheryn A Q Cousins; Garrett S Gibbons; Corey T McMillan; David A Wolk; Vivianna Van Deerlin; Lauren Elman; Meredith Spindler; Andres Deik; Andrew Siderowf; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin
Journal:  Acta Neuropathol       Date:  2020-08-17       Impact factor: 17.088

8.  Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Authors:  Cyril Pottier; Yingxue Ren; Ralph B Perkerson; Matt Baker; Gregory D Jenkins; Marka van Blitterswijk; Mariely DeJesus-Hernandez; Jeroen G J van Rooij; Melissa E Murray; Elizabeth Christopher; Shannon K McDonnell; Zachary Fogarty; Anthony Batzler; Shulan Tian; Cristina T Vicente; Billie Matchett; Anna M Karydas; Ging-Yuek Robin Hsiung; Harro Seelaar; Merel O Mol; Elizabeth C Finger; Caroline Graff; Linn Öijerstedt; Manuela Neumann; Peter Heutink; Matthis Synofzik; Carlo Wilke; Johannes Prudlo; Patrizia Rizzu; Javier Simon-Sanchez; Dieter Edbauer; Sigrun Roeber; Janine Diehl-Schmid; Bret M Evers; Andrew King; M Marsel Mesulam; Sandra Weintraub; Changiz Geula; Kevin F Bieniek; Leonard Petrucelli; Geoffrey L Ahern; Eric M Reiman; Bryan K Woodruff; Richard J Caselli; Edward D Huey; Martin R Farlow; Jordan Grafman; Simon Mead; Lea T Grinberg; Salvatore Spina; Murray Grossman; David J Irwin; Edward B Lee; EunRan Suh; Julie Snowden; David Mann; Nilufer Ertekin-Taner; Ryan J Uitti; Zbigniew K Wszolek; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; John R Hodges; Olivier Piguet; Ethan G Geier; Jennifer S Yokoyama; Robert A Rissman; Ekaterina Rogaeva; Julia Keith; Lorne Zinman; Maria Carmela Tartaglia; Nigel J Cairns; Carlos Cruchaga; Bernardino Ghetti; Julia Kofler; Oscar L Lopez; Thomas G Beach; Thomas Arzberger; Jochen Herms; Lawrence S Honig; Jean Paul Vonsattel; Glenda M Halliday; John B Kwok; Charles L White; Marla Gearing; Jonathan Glass; Sara Rollinson; Stuart Pickering-Brown; Jonathan D Rohrer; John Q Trojanowski; Vivianna Van Deerlin; Eileen H Bigio; Claire Troakes; Safa Al-Sarraj; Yan Asmann; Bruce L Miller; Neill R Graff-Radford; Bradley F Boeve; William W Seeley; Ian R A Mackenzie; John C van Swieten; Dennis W Dickson; Joanna M Biernacka; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2019-02-09       Impact factor: 17.088

9.  Genetic predictors of survival in behavioral variant frontotemporal degeneration.

Authors:  Carrie Caswell; Corey T McMillan; Sharon X Xie; Vivianna M Van Deerlin; EunRan Suh; Edward B Lee; John Q Trojanowski; Virginia M-Y Lee; David J Irwin; Murray Grossman; Lauren M Massimo
Journal:  Neurology       Date:  2019-09-19       Impact factor: 9.910

10.  SarkoSpin: A Technique for Biochemical Isolation and Characterization of Pathological TDP-43 Aggregates.

Authors:  Manuela Pérez-Berlanga; Florent Laferrière; Magdalini Polymenidou
Journal:  Bio Protoc       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.